FDA panel votes against approving Proscar, Avodart
FDA voted today against approving 2 drugs for the prevention of prostate cancer: finasteride (Proscar, Merck) and dutasteride (Avodart, GlaxoSmithKline). (Source: Drug Topics - Top News)

Patent expiries of Proscar, Flomax, and Omix will cause a significant decline in sales of benign prostatic hyperplasia drugs
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the patent expiries of Merck's Proscar, Boehringer Ingelheim's Flomax, and Astellas's Omix, combined with the limited emergence of new therapies, will cause a 23% decline in sales of therapies to treat benign prostatic hyperplasia over the next five years. (Source: News-Medical News Feed)div id=medwormpbiMedWorm Message:/i/b Please support the a href=http://www.doctorsinchains.org/ target=_blankDoctors In Chains/a campaign for the a href=http://www.doctorsinchains.org/medics/a tortured and sentenced for up to 15 years in a href=http://www.doctorsinchains.org/Bahrain/a. a href=https://twitter.com/#!/search/%23FreeDoctors#FreeDoctors/a/p/div